1. Home
  2. SWTX vs SYBT Comparison

SWTX vs SYBT Comparison

Compare SWTX & SYBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SWTX
  • SYBT
  • Stock Information
  • Founded
  • SWTX 2017
  • SYBT 1904
  • Country
  • SWTX United States
  • SYBT United States
  • Employees
  • SWTX N/A
  • SYBT N/A
  • Industry
  • SWTX Biotechnology: Pharmaceutical Preparations
  • SYBT Major Banks
  • Sector
  • SWTX Health Care
  • SYBT Finance
  • Exchange
  • SWTX Nasdaq
  • SYBT Nasdaq
  • Market Cap
  • SWTX 2.2B
  • SYBT 2.2B
  • IPO Year
  • SWTX 2019
  • SYBT N/A
  • Fundamental
  • Price
  • SWTX $36.45
  • SYBT $73.25
  • Analyst Decision
  • SWTX Strong Buy
  • SYBT Hold
  • Analyst Count
  • SWTX 5
  • SYBT 4
  • Target Price
  • SWTX $65.40
  • SYBT $65.25
  • AVG Volume (30 Days)
  • SWTX 1.3M
  • SYBT 201.0K
  • Earning Date
  • SWTX 11-12-2024
  • SYBT 10-23-2024
  • Dividend Yield
  • SWTX N/A
  • SYBT 1.69%
  • EPS Growth
  • SWTX N/A
  • SYBT N/A
  • EPS
  • SWTX N/A
  • SYBT 3.63
  • Revenue
  • SWTX $135,487,000.00
  • SYBT $331,807,000.00
  • Revenue This Year
  • SWTX $3,498.68
  • SYBT N/A
  • Revenue Next Year
  • SWTX $98.08
  • SYBT $7.24
  • P/E Ratio
  • SWTX N/A
  • SYBT $20.18
  • Revenue Growth
  • SWTX N/A
  • SYBT 1.02
  • 52 Week Low
  • SWTX $20.19
  • SYBT $42.35
  • 52 Week High
  • SWTX $53.92
  • SYBT $77.82
  • Technical
  • Relative Strength Index (RSI)
  • SWTX 71.38
  • SYBT 61.71
  • Support Level
  • SWTX $29.53
  • SYBT $71.87
  • Resistance Level
  • SWTX $35.26
  • SYBT $77.82
  • Average True Range (ATR)
  • SWTX 1.92
  • SYBT 2.33
  • MACD
  • SWTX 0.74
  • SYBT 0.47
  • Stochastic Oscillator
  • SWTX 87.38
  • SYBT 68.48

About SWTX SpringWorks Therapeutics Inc.

SpringWorks Therapeutics Inc is a clinical stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.

About SYBT Stock Yards Bancorp Inc.

Stock Yards Bancorp Inc operates as a bank. The bank has two reportable operating segments namely Commercial Banking and Wealth Management and trust. Its services include loan and deposit services, cash management services, securities brokerage activities, mortgage origination, and others. It generates a majority of its revenue from the Commercial Banking segment.

Share on Social Networks: